.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Persistent uncertainty surrounds the impact of micronutrients on hypertension management. However, a recent umbrella review clarifies the role of vitamin C for blood pressure regulation in adults. Researchers analyzed six meta-analyses comprising 17 randomized controlled trials (RCTs). They aimed to measure the magnitude of effect relative to clinical significance. The study indicates that vitamin C supplementation may offer an accessible adjunct to standard care.
The review found that vitamin C supplementation reduces systolic blood pressure (SBP) by approximately 3.7 mmHg. While this reduction might seem modest, even small drops in SBP significantly decrease cardiovascular risk across populations. Furthermore, the researchers observed a notable benefit in specific subgroups. For instance, patients with diabetes experienced a clinically important reduction in diastolic blood pressure (DBP) of 2.27 mmHg. Consequently, this suggests that the antioxidant properties of ascorbic acid may specifically target vascular stiffness in metabolic disorders.
Despite these promising results, the authors rated the certainty of evidence as low according to the GRADE approach. This low certainty highlights a critical need for larger, long-term randomized trials. Physicians should view vitamin C as a supportive measure rather than a replacement for primary antihypertensive medications. In addition, the magnitude of effect varies based on individual baseline levels and existing comorbidities. Therefore, personalized assessment remains essential when recommending supplements.
While vitamin C generally reduces systolic blood pressure in adults, its most significant impact on diastolic pressure appears specifically in patients with diabetes.
Currently, the evidence certainty is considered low. While the trends are positive, clinicians recommend larger, high-quality trials before making definitive changes to standard hypertension guidelines.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent umbrella review suggests that vitamin C supplementation can reduce systolic blood pressure by 3.7 mmHg and benefits diastolic levels in diabetics....
6 months ago
A nationwide English cohort study shows that interstitial lung diseases are no longer rare, with incidence jumping 30% and 200,000 active cases. This analysis highlights clinical implications for diagnosis, multi-disciplinary management, and global health priorities across respiratory and internal medicine.
Today
A nationwide South Korean study shows underreporting of smoking among women dropped from 57.4% to 36.4% between 2008 and 2021. However, over one-third of female smokers still conceal their habit, highlighting the critical role of cotinine verification in clinical risk assessment.
Today
PepsiCo and Monster Beverage have challenged the FSSAI ban on the energy drink label in Indian courts. While companies highlight supply disruptions, regulatory actions spotlight severe cardiovascular and metabolic risks associated with excessive caffeine, sugar, and taurine consumption, especially in adolescents.
Today
A new study evaluates the rheological stability of decellularized peripheral nerve matrix hydrogels under varied storage conditions. Findings show -80°C storage and freeze-drying preserve gelation kinetics and mechanical stiffness, offering key insights for shipping and translational clinical applications.
Today
A Bayesian multilevel meta-analysis reveals that aerobic training combined with moderate carbohydrate restriction modestly lowers HbA1c in type 2 diabetes. However, sparse data and very low certainty leave incremental benefits over exercise or diet alone unproven, highlighting the need for individualized care.
Yesterday
